AlphAIalphai — Financial news for AI agents
investing.comSEP 22 min read$HTFL

Heartflow Inc stock hits all-time high at 51.26 USD

HeartFlow Inc (HTFL) hit an all-time high of $51.26, with a 1-year return of 61.22% and a 6-month return of 110%. The company reported Q2 2026 earnings, with revenue of $64.1M, up 48% YoY, and adjusted loss of $0.07 per share, beating estimates. Stifel raised its price target to $45.00, maintaining a Buy rating.

Original reporting
investing.com
Published Sep 2, 2026, 1:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 2:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$HTFL
Bullish
medium confidence
Mentioned
$HTFL
Relevance
6/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$HTFLBullishMed
01

Why it matters

Earnings beat and price target raise could attract momentum traders.

02

Market read

Earnings surprise may trigger short-term price movement for HTFL.

03

What to watch

Potential reimbursement challenges and competition from larger imaging firms.

Relevance 6/10Novelty 7/10Timing: post-market release

Background

HeartFlow provides non-invasive coronary artery disease diagnostics using FFRCT technology.

Company-level read

Ticker impact

$HTFLBullishMedium confidence
Context

Q2 2026 earnings beat with revenue $64.1M and loss $0.07 per share, price target raised to $45.

Expected impact

Potential 5-8% rally in the next trading session.

Evidence & confidence

Revenue beat and upgraded price target suggest improved fundamentals, but small market cap limits scale.

Market effects

Sector

Strengthens outlook for cardiovascular diagnostics sector.

Regional

Limited to US biotech investors.

Global

Modest, confined to niche medical imaging market.

Counterpoint

What could challenge this read

Revenue growth may not be sustainable without broader adoption.

Key entities

  • Analyst
    Stifel

    Raised price target to $45.

Read at source← All news

Related articles

AUG 19
$HTFLMedAI 8/10

Why Heartflow Stock Soared Today

HeartFlow (HTFL) shares rose after the company raised its full-year revenue targets. Revenue grew 48% YoY to $64.1M in Q2, with adjusted gross margin increasing to 83.3%. The company now expects 40-42% revenue growth for 2026, up from prior forecasts. CEO John Farquhar cited improved operating leverage and scalability.

aol.com2 min
AUG 15
$HTFLMedAI 8/10

Analysts Are Bullish on Heartflow (HTFL) Stock. Here’s Why

Heartflow Inc. (NASDAQ:HTFL) hit a new all-time high after reporting Q2 revenue growth of 48% to $64.08 million from $43.2 million. The company raised full-year revenue guidance to 40% to 42% growth, targeting $246 million to $250 million. Net loss widened to $15.7 million. Analysts at Stifel and JPMorgan raised price targets to $45.

yahoo.com4 min